tetano
Editor, Senior Moderator
J Matern Fetal Neonatal Med
. 2020 Nov 29;1-7.
doi: 10.1080/14767058.2020.1850683. Online ahead of print.
Clinical course of novel COVID-19 infection in pregnant women
Roman G Shmakov[SUP] 1 [/SUP], Andrey Prikhodko[SUP] 2 [/SUP], Evgeniya Polushkina[SUP] 2 [/SUP], Elena Shmakova[SUP] 3 [/SUP], Aleksey Pyregov[SUP] 4 [/SUP], Vladimir Bychenko[SUP] 5 [/SUP], Tatyana V Priputnevich[SUP] 6 [/SUP], Grigory O Dolgushin[SUP] 3 [/SUP], Ekaterina Yarotskaya[SUP] 7 [/SUP], Oleg Pekarev[SUP] 1 [/SUP], Nikolai Bolibok[SUP] 3 [/SUP], Dmitriy Degtyarev[SUP] 3 [/SUP], Gennady T Sukhikh[SUP] 3 [/SUP]
Affiliations
Abstract
Objectives: Evaluation of clinical course of COVID-19 during pregnancy and maternal and perinatal outcomes of this pregnancy.
Methods: 66 women with polymerase chain reaction (PCR) - confirmed SARS-CoV-2 and their 42 neonates were included in the prospective observational study. Demographic, epidemiological, clinical, laboratory and instrumental data of pregnancy, delivery, postpartum period, including pharmacotherapy and neonatal outcomes were analyzed.
Results: 15 (22.7%) women were asymptomatic, 25 (38%) had mild disease, while moderate and severe forms were detected in 20 (30.2%) and 6 (9.1%) cases, respectively. Additional oxygenation was required in 6 (9%) cases: 4 (6%) received CPAP therapy and 2 (3%) - mechanical ventilation. Main clinical symptoms were cough (51.5%), anosmia (34.9%), and hyperthermia (33.3%). Laboratory changes included increased levels of lactate dehydrogenase (LDH), creatinine, d-dimer, and C-reactive protein (CRP), anemia, and leukopenia. All pregnant women received low molecular weight heparin and interferon alfa-2b according to the National clinical recommendations. Antimicrobial drugs included Amoxicillin/Clavulanic acid (46%) and macrolides (28%) or carbapenems in severe cases of disease. Spontaneous abortion was reported in 6.1% of cases. Eight preterm (19%) and 34 term deliveries (81%) occurred. The mean weight of neonates was (3283 ? 477) g, 1- and 5-min Apgar score was (7.8 ? 0.6) and (8.7 ? 0.5), respectively. No cases of neonatal COVID-19 infection were reported.
Conclusions: Mostly, the manifestations of COVID-19 were mild. However, 9% of cases were severe, and could contribute to preterm delivery or maternal morbidity. Main predictors of severe COVID-19 course in pregnant women were a decrease in the levels of erythrocytes and lymphocytes and increase in the levels of alanine aminotransferase and CRP. Elimination of the virus in pregnant women required more time due to altered immunity. No evidence of vertical transmission during pregnancy and delivery was found. However, the possibility of this cannot be excluded.
Keywords: COVID-19; Pregnancy; SARS-CoV-2; coronavirus; maternal and perinatal outcomes.
. 2020 Nov 29;1-7.
doi: 10.1080/14767058.2020.1850683. Online ahead of print.
Clinical course of novel COVID-19 infection in pregnant women
Roman G Shmakov[SUP] 1 [/SUP], Andrey Prikhodko[SUP] 2 [/SUP], Evgeniya Polushkina[SUP] 2 [/SUP], Elena Shmakova[SUP] 3 [/SUP], Aleksey Pyregov[SUP] 4 [/SUP], Vladimir Bychenko[SUP] 5 [/SUP], Tatyana V Priputnevich[SUP] 6 [/SUP], Grigory O Dolgushin[SUP] 3 [/SUP], Ekaterina Yarotskaya[SUP] 7 [/SUP], Oleg Pekarev[SUP] 1 [/SUP], Nikolai Bolibok[SUP] 3 [/SUP], Dmitriy Degtyarev[SUP] 3 [/SUP], Gennady T Sukhikh[SUP] 3 [/SUP]
Affiliations
- PMID: 33249969
- DOI: 10.1080/14767058.2020.1850683
Abstract
Objectives: Evaluation of clinical course of COVID-19 during pregnancy and maternal and perinatal outcomes of this pregnancy.
Methods: 66 women with polymerase chain reaction (PCR) - confirmed SARS-CoV-2 and their 42 neonates were included in the prospective observational study. Demographic, epidemiological, clinical, laboratory and instrumental data of pregnancy, delivery, postpartum period, including pharmacotherapy and neonatal outcomes were analyzed.
Results: 15 (22.7%) women were asymptomatic, 25 (38%) had mild disease, while moderate and severe forms were detected in 20 (30.2%) and 6 (9.1%) cases, respectively. Additional oxygenation was required in 6 (9%) cases: 4 (6%) received CPAP therapy and 2 (3%) - mechanical ventilation. Main clinical symptoms were cough (51.5%), anosmia (34.9%), and hyperthermia (33.3%). Laboratory changes included increased levels of lactate dehydrogenase (LDH), creatinine, d-dimer, and C-reactive protein (CRP), anemia, and leukopenia. All pregnant women received low molecular weight heparin and interferon alfa-2b according to the National clinical recommendations. Antimicrobial drugs included Amoxicillin/Clavulanic acid (46%) and macrolides (28%) or carbapenems in severe cases of disease. Spontaneous abortion was reported in 6.1% of cases. Eight preterm (19%) and 34 term deliveries (81%) occurred. The mean weight of neonates was (3283 ? 477) g, 1- and 5-min Apgar score was (7.8 ? 0.6) and (8.7 ? 0.5), respectively. No cases of neonatal COVID-19 infection were reported.
Conclusions: Mostly, the manifestations of COVID-19 were mild. However, 9% of cases were severe, and could contribute to preterm delivery or maternal morbidity. Main predictors of severe COVID-19 course in pregnant women were a decrease in the levels of erythrocytes and lymphocytes and increase in the levels of alanine aminotransferase and CRP. Elimination of the virus in pregnant women required more time due to altered immunity. No evidence of vertical transmission during pregnancy and delivery was found. However, the possibility of this cannot be excluded.
Keywords: COVID-19; Pregnancy; SARS-CoV-2; coronavirus; maternal and perinatal outcomes.